We are live on ! Find out more
DGM

Darwin Global Management Portfolio holdings

AUM $3.77B
1-Year Est. Return 307.72%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+307.72%
3 Year Est. Return
+2,873.14%
5 Year Est. Return
+48,315.58%
10 Year Est. Return
AUM
$188M
AUM Growth
+$78M
Cap. Flow
+$77.9M
Cap. Flow %
41.38%
Top 10 Hldgs %
100%
Holding
1
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$77.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
1
AstraZeneca
AZN
$262B
$188M 100%
1,424,555
+593,713
+71% +$77.9M

Similar funds

Darwin Global Management's Q2 2022 Portfolio in Review

As of Q2 2022, Darwin Global Management held 1 position worth $188M, up 71% from $110M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Darwin Global Management deployed $77.9M of net new capital in Q2 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Darwin Global Management added most to AstraZeneca in Q2 2022, an estimated $77.9M increase.
  • Darwin Global Management's ten largest holdings make up 100% of its $188M portfolio in Q2 2022.
  • Darwin Global Management opened 0 new positions and closed 0 in Q2 2022.
  • Darwin Global Management's portfolio value rose 71% quarter-over-quarter to $188M.

Based on Darwin Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.